PATENT CLAIM ANALYSIS

Application Number: 16112447
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "738000"]

Abstract:
The present invention provides compositions and methods of their use in treating muscular dystrophy and other disorders.

Claim (Index 3):
A method of reducing the incidence of a neuronal migration abnormality or other disorder or symptoms associated with a mutation in a FKRP gene in a subject known or suspected to have a mutation in the FKRP gene or without defect in glycosylation of \u03b1-DG, comprising administering to the mother of the subject, during the subject's gestation in the mother's uterus, an effective amount of a ribulose, thereby reducing the incidence of a neuronal migration abnormality, or other disorder or symptoms associated with a mutation in the FKRP gene of the subject.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15842580', '15880283', '15687196', '11143885', '15044598']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7545392280472129
- 35 USC 102 Novelty (BERT): 0.5992356581606502
- Combined Prediction Score: 0.7390088710585566
- Mean Citation Score: 411.0622320000001
- Max Citation Score: 661.2899
- Similarity Product: 407.7890582049608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test